Filtered By:
Source: Journal of Diabetes Investigation
Condition: Diabetes Mellitus
Management: Health Insurance
This page shows you your search results in order of date.
Order by Relevance | Date
Total 3 results found since Jan 2013.
Cardiovascular outcomes of vildagliptin in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke
ConclusionsAmong patients with type 2 diabetes mellitus after a recent acute coronary syndrome or acute ischemic stroke, treatment with vildagliptin was not associated with increased risks of CV death, non‐fatal myocardial infarction, non‐fatal stroke and hospitalization for HF.
Source: Journal of Diabetes Investigation - June 16, 2019 Category: Endocrinology Authors: Dong ‐Yi Chen,
Yan‐Rong Li,
Chun‐Tai Mao,
Chi‐Nan Tseng,
I‐Chang Hsieh,
Ming‐Jui Hung,
Pao‐Hsien Chu,
Chao‐Hung Wang,
Ming‐Shien Wen,
Wen‐Jin Cherng,
Tien‐Hsing Chen Tags: Original Article Source Type: research
Cardiovascular Outcomes of Vildagliptin in Patients with Type 2 Diabetes Mellitus after Acute Coronary Syndrome or Acute Ischemic Stroke
ConclusionsAmong patients with T2DM after a recent ACS or AIS, treatment with vildagliptin was not associated with increased risks of CV death, nonfatal MI, nonfatal stroke, and hospitalization for HF.This article is protected by copyright. All rights reserved.
Source: Journal of Diabetes Investigation - May 21, 2019 Category: Endocrinology Authors: Dong ‐Yi Chen,
Yan‐Rong Li,
Chun‐Tai Mao,
Chi‐Nan Tseng,
I‐Chang Hsieh,
Ming‐Jui Hung,
Pao‐Hsien Chu,
Chao‐Hung Wang,
Ming‐Shien Wen,
Wen‐Jin Cherng,
Tien‐Hsing Chen Tags: Original Article Source Type: research
